BEAT vs. AYTU
BEAT (Heartbeam, Inc.) and AYTU (Aytu BioPharma, Inc.) are both stocks. Over the past 3 years, BEAT returned -33.73%/yr vs 10.45%/yr for AYTU. At a 0.15 correlation, their price movements are largely independent.
Performance
BEAT vs. AYTU - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BEAT achieves a -70.41% return, which is significantly lower than AYTU's -13.46% return.
BEAT
- 1D
- -6.52%
- 1M
- -19.18%
- YTD
- -70.41%
- 6M
- -75.76%
- 1Y
- -53.28%
- 3Y*
- -33.73%
- 5Y*
- —
- 10Y*
- —
AYTU
- 1D
- -2.60%
- 1M
- 2.74%
- YTD
- -13.46%
- 6M
- -15.09%
- 1Y
- 12.50%
- 3Y*
- 10.45%
- 5Y*
- -54.31%
- 10Y*
- —
BEAT vs. AYTU - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
BEAT Heartbeam, Inc. | -70.41% | 4.35% | -2.13% | -51.84% | 58.44% | -42.96% |
AYTU Aytu BioPharma, Inc. | -13.46% | 52.94% | -40.14% | -24.87% | -86.00% | -43.28% |
Correlation
The correlation between BEAT and AYTU is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Nov 11, 2021 | 0.15 |
Fundamentals
BEAT:
$28.82M
AYTU:
$23.65M
BEAT:
-$0.57
AYTU:
-$2.91
BEAT:
45.39
AYTU:
0.67
BEAT:
$0.00
AYTU:
$56.60M
BEAT:
$0.00
AYTU:
$36.14M
BEAT:
-$20.29M
AYTU:
-$27.34M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BEAT vs. AYTU — Risk / Return Rank
BEAT
AYTU
BEAT vs. AYTU - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Heartbeam, Inc. (BEAT) and Aytu BioPharma, Inc. (AYTU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BEAT | AYTU | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.58 | ||
| Sortino ratioReturn per unit of downside risk | -0.39 | ||
| Omega ratioGain probability vs. loss probability | 1.04 | 1.09 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | -0.67 | 0.35 | -1.03 |
| Martin ratioReturn relative to average drawdown | -1.12 | 0.81 | -1.93 |
Loading charts...
Drawdowns
BEAT vs. AYTU - Drawdown Comparison
The maximum BEAT drawdown since its inception was -90.19%, smaller than the maximum AYTU drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for BEAT and AYTU.
Loading charts...
Drawdown Indicators
| BEAT | AYTU | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.19% | -100.00% | +9.81% |
Max Drawdown (1Y)Largest decline over 1 year | -79.36% | -35.47% | -43.89% |
Max Drawdown (3Y)Largest decline over 3 years | -82.13% | -70.24% | -11.89% |
Max Drawdown (5Y)Largest decline over 5 years | — | -99.09% | — |
Current DrawdownCurrent decline from peak | -88.05% | -100.00% | +11.95% |
Average DrawdownAverage peak-to-trough decline | -62.87% | -95.27% | +32.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 47.72% | 15.55% | +32.17% |
Volatility
BEAT vs. AYTU - Volatility Comparison
Heartbeam, Inc. (BEAT) and Aytu BioPharma, Inc. (AYTU) have volatilities of 15.82% and 16.13%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BEAT | AYTU | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.82% | 16.13% | -0.31% |
Volatility (6M)Calculated over the trailing 6-month period | 64.30% | 34.71% | +29.59% |
Volatility (1Y)Calculated over the trailing 1-year period | 150.21% | 55.79% | +94.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 117.47% | 85.38% | +32.09% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 117.47% | 187.85% | -70.38% |
Dividends
BEAT vs. AYTU - Dividend Comparison
Neither BEAT nor AYTU has paid dividends to shareholders.
Financials
BEAT vs. AYTU - Financials Comparison
This section allows you to compare key financial metrics between Heartbeam, Inc. and Aytu BioPharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
BEAT and AYTU have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AYTU has higher volatility (16.13%) compared to BEAT (15.82%). In terms of maximum drawdown, BEAT dropped -90.19% vs AYTU's -100.00%.
AYTU currently has the higher Sharpe Ratio (0.23 vs -0.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BEAT and AYTU
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer